Frontier IP Group Plc reported unaudited consolidated earnings results for the six months ended December 31, 2012. The company’s total revenue was £104,000 compared to £119,000 a year ago. Loss before tax and loss and total comprehensive expense for the period was £85,000 compared to £187,000 a year ago, decrease mainly being due to the release of the bad debt provision against Nandi Proteins Ltd. of £119,000. Basic and diluted Loss per share was 1.06 pence compared to 2.68 pence a year ago. Net cash used in operating activities was £220,000 compared to £231,000 a year ago. Purchase of financial assets at fair value through profit and loss was £19,000 compared to £52,000 a year ago.

Frontier IP Group Plc, Annual General Meeting, Dec 31, 2012. Location: 41 Charlotte Square.

Frontier IP Group Plc and its portfolio company, Nandi Proteins Limited announced that Nandi Proteins Limited has concluded a license agreement for the use of its innovative protein technology with Tate & Lyle plc The conclusion of the license agreement will result in the payment of advisory fees to Frontier IP and is expected to result in an uplift in the valuation of Nandi.